MariMed Inc (OTCMKTS:MRMD) is an exceptional multistate, seed-to-sale company that is, for now, overlooked and undervalued. It reported record 2020 results and impressive results for the first quarter of 2021. That momentum is expected to continue throughout 2021 and beyond.